Skip to main content

NCT00216502 - Long Term Treatment With Galantamine In Dementia

Long Term Treatment With Galantamine In Dementia


Data Specification

Not Available


Annotated CRF

Not Available

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.

Product Info

Generic Name
Galantamine
Product Name
RAZADYNE®
Therapeutic Area
Behaviors and Mental Disorders
Enrollment
254
% Female
61.4%
% White
N/A
Product Class
Alzheimer's Disease - Cholinesterase Inhibitors
Sponsor Protocol Number
GAL ITA-2
Data Holder
Johnson & Johnson
Condition Studied
Alzheimer Disease
Mean/Median Age (Years)
74.2

Supporting Documentation

Data Definition Specification Available
Annotated Case Report Form Available
Clinical Study Report
Protocol with Amendments
Study Phase 
3
Additional Information: 

For CSR: only report body is available, no supporting data

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.